Brief: Almirall Gets 16.8 Mln Euros From CDTI For Dermatology Development
22/01/2026 09:19
Jan 22 (Reuters) - Almirall SA ALM.MC: CDTI INNOVATION CENTRE AWARDS ALMIRALL TWO GRANTS TOTALLING 16.8 MILLION EUROS FOR RESEARCH AND DEVELOPMENT PROJECTS IN MEDICAL DERMATOLOGY Further company coverage: ALM.MC (Gdansk newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10))
Recent news on Almirall
See all newsBrief: Almirall Says Phase 3B Adlong Clinical Study Show Treatment Outcomes With Up To Five Years Of Lebrikizumab
Brief: Almirall And CrystalO To Discover, Develop Novel Small Molecules In Medical Dermatology
Almirall shares rise as lower costs beat EBITDA estimates
Brief: Almirall, Certest Biotec Sign Deal to Develop Rare Dermatology Treatments
Spanish stocks - Factors to watch on July 24